| Authors: |
Varodayan FP; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Developmental Exposure Alcohol Research Center and Behavioral Neuroscience Program, Department of Psychology, Binghamton University, State University of New York, Binghamton, New York., Patel RR; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California; Systems Neurobiology Laboratory, Salk Institute for Biological Studies, La Jolla, California., Matzeu A; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Wolfe SA; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Curley DE; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Neuroscience Graduate Program, Department of Neuroscience, Brown University, Providence, Rhode Island., Khom S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Gandhi PJ; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Rodriguez L; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Bajo M; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., D'Ambrosio S; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Sun H; Clinical Core Laboratory, Office of the Clinical Director, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland., Kerr TM; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Gonzales RA; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Leggio L; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland; Medication Development Program, National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Baltimore, Maryland; Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland; Department of Neuroscience, Georgetown University Medical Center, Washington, DC., Natividad LA; College of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, Texas., Haass-Koffler CL; Center for Alcohol and Addiction Studies, Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, Rhode Island; Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island; Carney Institute for Brain Science, Brown University, Providence, Rhode Island; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Division of Intramural Clinical and Biological Research, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; Clinical Psychoneuroendocrinology and Neuropsychopharmacology Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program, Baltimore, Maryland., Martin-Fardon R; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California., Roberto M; Department of Molecular Medicine, The Scripps Research Institute, La Jolla, California. Electronic address: mroberto@scripps.edu. |
